Skip to main content
. 2007 Dec 12;82(6):3125–3130. doi: 10.1128/JVI.01533-07

FIG. 2.

FIG. 2.

Rates of hypermutation in ESs versus patients on HAART. The percentage of hypermutated genomes amplified from resting CD4+ T cells from ESs and patients on HAART is shown. Patient ES3 had an unusually high frequency of hypermutated proviral sequences.

HHS Vulnerability Disclosure